Sept 28- The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc's "artificial pancreas" designed to automatically deliver the right dose of insulin to patients with type 1 diabetes. Jeffrey Shuren, director of the FDA's medical device division said in a statement. "This device will mean peace of mind, in knowing a person will be in normal blood...
Sept 8- Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process. The companies are considering using former Delaware...
Sept 6- Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher will pay $53 per share in cash, a premium of 54 percent to Cepheid's close of $34.42 on Friday. 1/ 8 nPn10sKcxa. Cepheid had revenue of $539 million last year, and is expecting $618...
Aug 31- Tecomet Inc, a privately held U.S. contract manufacturer of medical devices and surgical instruments, is exploring a sale that could value it at more than $1 billion, including debt, according to people familiar with the matter. Genstar Capital, the private equity firm that owns Tecomet, has hired investment bank William Blair& Company, LLC to run an auction...
St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.
Check out the companies making headlines after the bell Tuesday.
HeartWare stock soared more than 90 percent on news that the company will be acquired by Medtronic.
CNBC's Diana Olick takes a look at bringing deskercise to the classroom.
Thermo Fisher Scientific said it would buy FEI for about $4.2 billion to gain access to its signature electron microscopy technology.
An invention that debuted Thursday could let you see all the spots you're missing when you brush.
A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
Bill Ackman should have listened!
Ben Young, Sworkit founder & CEO, explains how a new fitness app allows users to customize personalized workout videos.
Loncar Investments CEO, Brad Loncar says immunotherapy is the most innovative, high-growth area in the biotech space, while describing the company’s ETF.
Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.
Jonathan Adiri, CEO of Healthy.io, discusses how smart phones, wearables and tech will impact health care.
U.S. health inspectors found problems at Theranos' northern California laboratory.
In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'